President & CEO of Homology Medicines, Inc. (U.S.: Nasdaq:FIXX), Tzianabos Arthur, sells 5,354 shares worth $20,239
According to Homology Medicines, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 04:05 PM, company President & CEO, Tzianabos Arthur disclosed selling 5,354 shares at a cost of $3.78. At the time of this transaction (Jan 05), this trade was worth $20,239 in total. As of Jan 05, Tzianabos Arthur now owns 86,011 shares in total worth about $316,090.425.
For the last few recent trades made by Homology Medicines, Inc. (U.S.: Nasdaq:FIXX) President & CEO, Tzianabos Arthur, we have the following information:
- SEC Form 4 filing: Feb 03: Sold 12,500 shares at the rate of $16.16 per share. Total worth of this trade was $202,021. Total number of shares owned as of Feb 03 were 77,505
- SEC Form 4 filing: Jan 02: Sold 12,500 shares at the rate of $20.50 per share. Total worth of this trade was $256,191. Total number of shares owned as of Jan 02 were 90,005
- SEC Form 4 filing: Nov 29: Sold 12,500 shares at the rate of $16.04 per share. Total worth of this trade was $200,559. Total number of shares owned as of Nov 29 were 115,005
Posted by
George Daniels
on Thursday January 13 2022, 1:25 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
